TD Cowen analyst Ken Cacciatore reiterated a Buy rating and $25.00 price target on scPharmaceuticals (NASDAQ: SCPH).The analyst commented, "SCPH ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE